NovoCure Limited (NASDAQ:NVCR) Q4 2022 Earnings Call Transcript

NovoCure Limited (NASDAQ:NVCR) Q4 2022 Earnings Call Transcript February 23, 2023

Ingrid Goldberg: Good morning, everyone, and thank you for joining us to review Novocure’s Fourth Quarter and Full Year 2022 Performance. I’m joined on the phone by our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Ashley Cordova. Other members of our executive leadership team are also on the call and available for Q&A. For your reference, slides accompanying this earnings release can be...